TAP1 and cutaneous melanoma: Loss of TAP1 expression in cutaneous melanoma is associated with an increase in regulatory T (Treg) cells and neutrophils in cancer, which might alter the immune microenvironment and be involved in reversing resistance to PD1 therapy [13, 14].